Description and Brand Names
Drug information provided by: IBM Micromedex
Sacituzumab govitecan-hziy injection is used to treat metastatic (cancer that has already spread) triple-negative breast cancer (mTNBC) in patients who have received at least two metastatic cancer treatments. It belongs to the group of medicines called antineoplastics (cancer medicines).
Sacituzumab govitecan-hziy interferes with the growth of cancer cells, which are eventually destroyed. Since the growth of normal cells may also be affected by the medicine, other effects may also occur. Some of these may be serious and must be reported to your doctor.
This medicine is to be given only by or under the immediate supervision of your doctor.
This product is available in the following dosage forms: